title: Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Honoré
authors.forename: Rita
authors.initials: R
authors.lastname: Jacobs
authors.forename: Jouke
authors.initials: J
authors.lastname: De Regt
authors.forename: Viola
authors.initials: V
authors.lastname: Van Gorp
authors.forename: Elisabeth
authors.initials: E
authors.lastname: De Waele
authors.forename: Herbert D
authors.initials: HD
authors.lastname: Spapen
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D003091:Colistin / Q000008:administration & dosage*; D016638:Critical Illness / Q000453:epidemiology / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D018432:Drug Resistance, Multiple / Q000187:drug effects*; D006801:Humans; D011549:Pseudomonas / Q000187:drug effects; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000453:epidemiology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D003091:Colistin